OCA Ventures
Jay Yarlagadda, MD, MBA, currently serves as a General Partner at ATOMS VC since September 2022 and has extensive experience as Clinical Internal Medicine Faculty at both UChicago Medicine and OSF HealthCare, overseeing inpatient acute care and multidisciplinary teams. Additionally, Yarlagadda holds positions as a venture capital investor with OCA Ventures and formerly with Independence Equity, and is involved in various advisory roles including Chief Medical Officer and advisory board member for several healthcare-focused organizations, such as MD Newsline and Shevolve Nutrition. Yarlagadda completed an MBA at The University of Chicago Booth School of Business and holds an MD from Thomas Jefferson University.
OCA Ventures
OCA Ventures is an early stage (Seed, Series A, and Series B) venture capital firm focused on equity investments in companies with dramatic growth potential, primarily in technology and highly-scalable services businesses. OCA invests in many industries, with a preference for technology, financial services, education and healthcare technology. Founded in 1999, the firm is investing out of its fourth fund in companies spread throughout the United States.